ADAM-17: a novel therapeutic target for triple negative breast cancer (vol 24, pg 362, 2013)

被引：0
|
作者：
McGowan, P. M.
机构：
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷 / 08期
关键词：
D O I：
10.1093/annonc/mdt285
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2199 / 2199
页数：1
相关论文
共 50 条
  • [31] cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?
    Gaule, Patricia B.
    Crown, John
    O'Donovan, Norma
    Duffy, Michael J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (09) : 999 - 1009
  • [32] CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
    Dai, Meiou
    Zhang, Chenjing
    Ali, Ayad
    Hong, Xinyuan
    Tian, Jun
    Lo, Chieh
    Fils-Aime, Nadege
    Burgos, Sergio A.
    Ali, Suhad
    Lebrun, Jean-Jacques
    SCIENTIFIC REPORTS, 2016, 6
  • [33] CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
    Meiou Dai
    Chenjing Zhang
    Ayad Ali
    Xinyuan Hong
    Jun Tian
    Chieh Lo
    Nadège Fils-Aimé
    Sergio A. Burgos
    Suhad Ali
    Jean-Jacques Lebrun
    Scientific Reports, 6
  • [34] Glutathione peroxidase 8 (GPX8) as a novel therapeutic target in triple negative breast cancer
    Khatib, Anees
    CANCER RESEARCH, 2022, 82 (04)
  • [35] EMP2 regulates the tumor microenvironment and is a novel therapeutic target for triple negative breast cancer
    Goodglick, Lee
    Fu, Maoyong
    Braun, Jonathan
    Wadehra, Madhuri
    CANCER RESEARCH, 2012, 72
  • [36] Biological functions of ERβ in triple negative breast cancer and its utility as a novel therapeutic drug target
    Reese, J. M.
    Bruinsma, E. S.
    Suman, V. J.
    Nelson, A. W.
    Chernukhin, I.
    Carroll, J. S.
    Ingle, J. N.
    Goetz, M. P.
    Hawse, J. R.
    CANCER RESEARCH, 2017, 77
  • [37] ZBTB7A is a tumor suppressor and novel therapeutic target in triple-negative breast cancer
    Molloy, Mary Ellen
    Lewinska, Monika
    Liu, Xue-Song
    Wang, Angela A.
    Yuan, Zhi-Min
    CANCER RESEARCH, 2016, 76
  • [38] CHK1 AS A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER
    Quidville, V.
    Albiges-Sauvin, L.
    Goubar, A.
    Scott, V.
    Andre, F.
    ANNALS OF ONCOLOGY, 2011, 22 : 51 - 52
  • [39] Erk5 as a therapeutic target in triple negative breast cancer (TNBC)
    Miranda, Mariska Sauzine
    Al Ejeh, Fares
    Shi, Wei
    Simpson, Peter
    Lakhani, Sunil
    Khanna, Kum Kum
    CANCER RESEARCH, 2015, 75
  • [40] Innate immunity as a target for novel therapeutics in triple negative breast cancer
    Borgovan, Theo
    Yanamandra, Niranjan
    Schmidt, Hank
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (08) : 781 - 794
12345